Syngene International Limited (NSE:SYNGENE)
359.60
-3.60 (-0.99%)
Oct 7, 2026, 12:36 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 143.16 billion as of October 6, 2026. Its market cap has decreased by -43.33% in one year.
Market Cap
143.16B
Enterprise Value
134.85B
Revenue
36.00B
Ranking
n/a
PE Ratio
66.43
Stock Price
359.60
ChartMarket Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 143.16B, an increase of 130.49%. That is a compound annual growth rate of 7.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 143.16B | -44.76% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.32T |
| Divi's Laboratories | 2.46T |
| Lenskart Solutions | 1.20T |
| Apollo Hospitals Enterprise | 1.17T |
| Dr. Agarwal's Health Care | 154.20B |
| Marksans Pharma | 147.55B |
| NATCO Pharma | 147.10B |
| Vijaya Diagnostic Centre | 146.94B |